Yahoo Finance12d
Recce Pharmaceuticals Advances Patient Dosing to Final Stages in Phase II Trial for Acute Bacterial Skin and Skin Structure Infections
About Recce Pharmaceuticals Ltd Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) is developing a New Class of Synthetic Anti-Infectives designed to address the urgent global health problems of ...
Nasdaq4d
Recce Pharmaceuticals Boosted by $6.75M R&D Rebate
Recce Pharmaceuticals Ltd. (AU:RCE) has released an update. Recce Pharmaceuticals Ltd has secured a significant AUD $6.75 million R&D Tax Incentive rebate from the Australian Taxation Office ...
Yahoo Finance5d
Recce Pharmaceuticals receives approval for Phase III DFI trial in Indonesia
Recce Pharmaceuticals (Recce) has obtained approval from the Human Research Ethics Committee in Indonesia to initiate a registrational Phase III trial of its RECCE 327 (R327G) as a topical gel ...
Business Insider8d
Recce Pharmaceuticals Advances Phase 3 Trial in Indonesia
Recce Pharmaceuticals Ltd. (AU:RCE) has released an update. Recce Pharmaceuticals is set to begin a pivotal Phase 3 clinical trial in Indonesia for their RECCE 327 topical gel, targeting diabetic ...
Adelaide Now13d
Recce Phase II clinical trial reaches key dosing milestone
A Phase II clinical trial for acute bacterial skin and skin structure infections reaches a dosing milestone. Clinical stage biotech company Recce Pharmaceuticals (ASX:RCE) is developing a new ...
The Daily Telegraph7d
Break it Down: Recce Pharmaceuticals gets Indonesian entry for clinical trial
Stockhead TV’s Sarah Hughan brings you today’s Break it Down, detailing the new diabetic foot infection treatment trial from Recce Pharmaceuticals. In this episode, host Sarah Hughan tells all ...
Hosted on MSN21d
Recce Pharmaceuticals’ R327 Gel Shows Promising Trial Results
Recce Pharmaceuticals Ltd. (AU:RCE) has released an update. Recce Pharmaceuticals has announced promising interim results from its Phase II trial for the R327 Gel, a new anti-infective treatment ...